LabCorp strikes deal for Alzheimer's disease diagnostic
LabCorp has struck a deal to develop and commercialize a new Alzheimer's disease diagnostic.
A simple, non-invasive blood test can detect Alzheimer's disease in its early stages long before its devastation is identified, claim researchers in Canada and the US.